DCSIMG
KNOW LOVENOX®

If you are receiving epidural or spinal anesthesia or undergoing spinal puncture, and taking LOVENOX®, you may be at increased risk of developing a blood clot in or around the spine, which can result in long-term paralysis. Your risk may be further increased if you:

  • Take nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, or other anticoagulants, such as aspirin or blood thinners
  • Have an indwelling epidural catheter
  • Have a history of spinal trauma, or repeated spinal anesthesia or punctures
  • Have a history of spinal deformities or spinal surgery

It is important to contact your doctor immediately if you experience symptoms such as tingling, numbness (especially in the lower limbs), and muscular weakness.

Glossary

Anticoagulant
A medicine that decreases the blood’s ability to clot, therefore lessening the risk of developing DVT blood clots.
Arteries:
Thick-walled vessels that carry oxygen-rich blood away from the heart.
Blood clot:
A firm mass of thickened blood.
CHF:
Congestive heart failure, a condition in which the heart is unable to pump enough blood to the body's other organs; increases the risk of DVT blood clots.
COPD:
Chronic obstructive pulmonary disease, a respiratory condition characterized by cough, shortness of breath, and an increase in mucus that may increase the risk of DVT blood clots.
Deep vein thrombosis (DVT):
Formation of blood clots in veins located deep within the muscles, usually in the legs.
Embolism:
Sudden blockage of a vein by a blood clot that breaks free and travels through the bloodstream.
Heparin:
An anticoagulant commonly used to reduce the risk of and treat blood clots.
Immobility:
Inability to move.
Low-molecular-weight heparin:
An anticoagulant commonly used to reduce the risk of and treat blood clots, particularly DVT. LOVENOX® is an example of a low-molecular-weight heparin.
Platelet:
Small, flat disks in the blood that aid in clotting.
Prophylaxis:
A measure taken for the prevention of a disease or condition.
Pulmonary artery:
Carries deoxygenated blood from the right ventricle of the heart to the lungs.
Pulmonary embolism:
A DVT blood clot that travels from the leg through blood circulation and becomes lodged in the lung.
Thromboembolism:
A blood clot moving through the blood vessels.
Thrombus:
A blood clot that forms inside a blood vessel or cavity of the heart.
Veins:
Thin-walled vessels that carry deoxygenated blood to the heart.
Warfarin:
An anticoagulant commonly used to reduce the risk of and treat blood clots.


Important Safety Information for LOVENOX®

If you are receiving epidural or spinal anesthesia or undergoing spinal puncture, and taking LOVENOX® (enoxaparin sodium injection), you may be at increased risk of developing a blood clot in or around the spine, which can result in long-term paralysis. Your risk may be further increased if you:

  • Take nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, or other anticoagulants, such as aspirin or blood thinners
  • Have an indwelling epidural catheter
  • Have a history of spinal trauma, or repeated spinal anesthesia or punctures
  • Have a history of spinal deformities or spinal surgery

It is important to contact your doctor immediately if you experience symptoms such as tingling, numbness (especially in the lower limbs), and muscular weakness.

LOVENOX® should not be used in patients who are actively bleeding or who have a low count of blood cells called platelets, which aid in clotting. This is a condition called "thrombocytopenia." LOVENOX® also should not be used in patients who are allergic or sensitive to LOVENOX® or enoxaparin, heparin, or pork products.

LOVENOX® must be used with care in patients who have any of the following: problems with clotting, uncontrolled high blood pressure, a recent ulcer, impaired vision due to diabetes, kidney problems, and excessive bleeding. Pregnant women with mechanical prosthetic (artificial) heart valves may be at higher risk for blood clots. These patients who are treated with LOVENOX® must be carefully monitored by their doctor.

Some patients on LOVENOX® can experience drops in their platelet counts, a condition called "thrombocytopenia." Also, a serious but rare condition called "heparin-induced thrombocytopenia" can occur with LOVENOX®. If you have had this condition, you must notify your healthcare professional.

LOVENOX® alters the blood’s ability to clot. Excessive bleeding (hemorrhage), leading to death, has occurred with LOVENOX®. Bleeding can occur at any site with LOVENOX® use. The use of aspirin and other NSAIDs may enhance the risk of excessive bleeding. Be sure to tell all your doctors and dentist about all of the medications you are taking, including those you are taking without a prescription, such as aspirin or other NSAIDs. Also be sure to tell your doctor or dentist you are taking LOVENOX® before any surgery is scheduled and before any new drug is taken.

All patients should be carefully monitored by their doctor while taking LOVENOX®. Your doctor is likely to obtain blood tests that measure your blood count and check for signs of hidden bleeding while you are on LOVENOX®.

You should call your doctor immediately if you notice any of the following: unusual bleeding or bleeding that lasts a long time, unusual bruising, signs of thrombocytopenia (such as a rash or dark spots under the skin), tingling or numbness (especially in the lower limbs), and muscular weakness.

The most common side effects from the use of LOVENOX® are mild pain, irritation, bruising, or redness of the skin at the site of injection. Other common side effects include bleeding, anemia, diarrhea, and nausea.

Do not stop taking LOVENOX® without first talking to the doctor who prescribed it for you.

For specific questions about your health, you should always consult your doctor or a qualified healthcare professional who is responsible for your care.

For more information, call sanofi-aventis U.S. Medical Information Services at 1-800-633-1610.


Indications

LOVENOX® can help reduce the risk of developing DVT blood clots, which may lead to PE, in patients undergoing abdominal surgery, hip- or knee-replacement surgery, or in acutely ill medical patients with severely restricted mobility.

Please see Full Prescribing Information, including boxed WARNING, for additional important information.

Prescription LOVENOX® is available in pharmacies.

Click here for information on Sharps Medical Waste Disposal.